For Patients
Investors
Home
Who We Are
Get to Know KORU
Testimonials
Our Story
Executive Team
Careers
Therapeutic Areas
PIDD
CIDP
PNH
Infectious Diseases
International Use
Plasma Donation
Products
Freedom Integrated Infusion System
FREEDOM60
FreedomEdge
Precision Flow Rate Tubing
HIgH-Flo Needle Sets
Resource Hub
IVIg vs. SCIg
Hospital vs. Homecare
Optimizing Infusions
IgG Calculator
Training
Resources
News
Partners
Contact Us
Contact Info
Submit Inquiry
Symbols Glossary
Search
All SEC Filings
Investors
Investors
Overview
News / Events
Overview
Press Releases
IR Calendar
Media
Email Alerts
Company Info
Overview
Management Team
Presentations
Contacts
FAQ
Financial Info
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Filing Type:
View All
10-K
10-K/A
10-KT
10-Q
10-Q/A
10KSB
10KSB/A
10QSB
10QSB/A
3
3/A
4
4/A
424B3
424B5
5
5/A
8-A12B
8-A12B/A
8-K
8-K/A
CERT
CORRESP
DEF 14A
DEFA14A
EFFECT
NT 10-K
NT 10-Q
POS AM
PRE 14A
REGDEX
S-1
S-1/A
S-3
S-3/A
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
UPLOAD
Year:
View All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
Date
Form
Description
PDF
XBRL
Pages
03/28/24
DEF 14A
Definitive proxy statements
46
03/18/24
PRE 14A
Preliminary proxy statement not related to a contested matter or merger/acquisition
44
03/15/24
4
Statement of changes in beneficial ownership of securities
1
03/13/24
8-K
Current report filing
Documents
EX-10
EX-10
EX-99
57
03/13/24
10-K
Annual report pursuant to Section 13 and 15(d)
Documents
EX-23
EX-31
EX-31
EX-32
EX-32
61
02/16/24
4
Statement of changes in beneficial ownership of securities
2
02/14/24
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
7
02/13/24
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
9
01/12/24
4
Statement of changes in beneficial ownership of securities
2
01/02/24
4
Statement of changes in beneficial ownership of securities
Documents
EX-99
3
Previous
1
2
3
4
5
6
7
8
9
10
Next
Email Alerts
Tear Sheet
Contacts
RSS News Feed